首页 | 本学科首页   官方微博 | 高级检索  
     


Causes of Death in a Contemporary Cohort of Patients with Invasive Aspergillosis
Authors:Carolina Garcia-Vidal  Maddalena Peghin  Carlos Cervera  Carlota Gudiol  Isabel Ruiz-Camps  Asunción Moreno  Cristina Royo-Cebrecos  Eva Roselló   Jordi Puig de la Bellacasa  Josefina Ayats  Jordi Carratalà
Affiliation:1. Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL (Institut d´Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain.; 2. REIPI (Spanish Network for Research in Infectious Diseases), Barcelona, Spain.; 3. Hospital Universitari de la Vall d’Hebron, Barcelona, Spain.; 4. Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; Fred Hutchinson Cancer Center, UNITED STATES,
Abstract:Information regarding the processes leading to death in patients with invasive aspergillosis (IA) is lacking. We sought to determine the causes of death in these patients, the role that IA played in the cause, and the timing of death. The factors associated with IA-related mortality are also analyzed. We conducted a multicenter study (2008-2011) of cases of proven and probable IA. The causes of death and whether mortality was judged to be IA-related or IA-unrelated were determined by consensus using a six-member review panel. A multivariate analysis was performed to determine risk factors for IA-related death. Of 152 patients with IA, 92 (60.5%) died. Mortality was judged to be IA-related in 62 cases and IA-unrelated in 30. The most common cause of IA-related death was respiratory failure (50/62 patients), caused primarily by Aspergillus infection, although also by concomitant infections or severe comorbidities. Progression of underlying disease and bacteremic shock were the most frequent causes of IA-unrelated death. IA-related mortality accounted for 98% and 87% of deaths within the first 14 and 21 days, respectively. Liver disease (HR 4.54; 95% CI, 1.69-12.23) was independently associated with IA-related mortality, whereas voriconazole treatment was associated with reduced risk of death (HR 0.43; 95% CI, 0.20-0.93). In conclusion, better management of lung injury after IA diagnosis is the main challenge for physicians to improve IA outcomes. There are significant differences in causes and timing between IA-related and IA–unrelated mortality and these should be considered in future research to assess the quality of IA care.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号